Cancer has become the most life-threatening disease in the world.Mutations in and aberrant expression of genes encoding proteins and mutations in noncoding RNAs,especially long noncoding RNAs(lncRNAs),have significant...Cancer has become the most life-threatening disease in the world.Mutations in and aberrant expression of genes encoding proteins and mutations in noncoding RNAs,especially long noncoding RNAs(lncRNAs),have significant effects in human cancers.LncRNAs have no protein-coding ability but function extensively in numerous physiological and pathological processes.Small nucleolar RNA host gene 3(SNHG3)is a novel lncRNA and has been reported to be differentially expressed in various tumors,such as liver cancer,gastric cancer,and glioma.However,the interaction mechanisms for the regulation between SNHG3 and tumor progression are poorly understood.In this review,we summarize the results of SNHG3 studies in humans,animal models,and cells to underline the expression and role of SNHG3 in cancer.SNHG3 expression is upregulated in most tumors and is detrimental to patient prognosis.SNHG3 expression in lung adenocarcinoma remains controversial.Concurrently,SNHG3 affects oncogenes and tumor suppressor genes through various mechanisms,including competing endogenous RNA effects.A deeper understanding of the contribution of SNHG3 in clinical applications and tumor development may provide a new target for cancer diagnosis and treatment.展开更多
目的探究胰腺癌患者血清长链非编码RNA-核仁小分子RNA宿主基因11(lncRNA-SNHG11)的表达水平及其临床意义。方法选择2013年7月~2015年2月邯郸市中心医院诊治的120例胰腺癌患者作为胰腺癌组,选择同期在邯郸市中心医院诊治的120例胰腺炎患...目的探究胰腺癌患者血清长链非编码RNA-核仁小分子RNA宿主基因11(lncRNA-SNHG11)的表达水平及其临床意义。方法选择2013年7月~2015年2月邯郸市中心医院诊治的120例胰腺癌患者作为胰腺癌组,选择同期在邯郸市中心医院诊治的120例胰腺炎患者作为胰腺炎组,选择同期在该院进行体检的120例健康者作为对照组。检测胰腺癌组患者癌组织及癌旁组织lncRNA-SNHG11表达水平,比较三组血清lncRNA-SNHG11表达水平。分析血清lncRNA-SNHG11表达水平与胰腺癌患者临床病理参数之间的关系。采用Kaplan-Meier法进行生存分析。采用受试者工作特征曲线(ROC)分析血清lncRNA-SNHG11检测对胰腺癌的诊断价值。结果胰腺癌组织lncRNA-SNHG11表达水平高于癌旁正常组织(6.25±1.74 vs 1.21±0.35),差异有统计学意义(t=31.107,P=0.000)。胰腺癌组血清lncRNASNHG11表达水平(18.45±4.08)高于胰腺炎组(4.13±1.29),差异有统计学意义(t=36.659,P=0.000),胰腺炎组血清lncRNA-SNHG11表达水平高于对照组(1.05±0.31),差异具有统计学意义(t=25.431,P=0.000)。有糖尿病史、有吸烟史、肥胖、饮酒、有慢性胰腺炎、有淋巴结转移、CA199≥37U/ml,TNM分期为Ⅲ期的胰腺癌患者,血清lncRNA-SNHG11表达水平高于无糖尿病史、无吸烟史、非肥胖、不饮酒、无慢性胰腺炎、无淋巴结转移、血清CA199<37U/ml和TNM分期Ⅰ+Ⅱ期的患者(20.78±4.14 vs 17.33±3.28,20.64±4.16 vs 17.27±3.97,21.45±5.03 vs 17.11±4.22,19.75±4.17 vs 17.95±3.98,20.06±4.24 vs 18.79±3.95,21.06±3.18 vs 16.19±2.37,18.99±3.08 vs 16.29±2.27和20.97±3.23 vs 17.19±3.37),差异均有统计学意义(t=2.272~9.586,均P<0.05)。以lncRNA-SNHG11表达水平的中位数为界,将患者分为lncRNA-SNHG11低表达患者和lncRNA-SNHG11高表达患者,Kaplan-Meier生存分析结果显示,血清lncRNA-SNHG11低表达患者的5年生存率明显高于高表达患者(21.82%vs 7.69%),差异有统计学意义(Log-rankχ^(2)=6.937,P<0.05)。血清lncRNA-SNHG11检测诊断胰腺癌的曲线下面积(AUC)为0.912(95%CI:0.877~0.945),最佳截断值为18.37,灵敏度和特异度分别为0.75,0.82。CA199的AUC为0.854(95%CI:0.777~0.899),灵敏度和特异度分别为0.71,0.73。结论在胰腺癌患者中血清lncRNA-SNHG11表达水平异常升高。血清lncRNA-SNHG11高表达与淋巴结转移、TNM分期及胰腺癌患者预后密切相关,可作为胰腺癌患者诊断的辅助指标。展开更多
基金Supported by the National Science and Technology Major Project of China,No. 2018ZX10302206 and 2017ZX10202203
文摘Cancer has become the most life-threatening disease in the world.Mutations in and aberrant expression of genes encoding proteins and mutations in noncoding RNAs,especially long noncoding RNAs(lncRNAs),have significant effects in human cancers.LncRNAs have no protein-coding ability but function extensively in numerous physiological and pathological processes.Small nucleolar RNA host gene 3(SNHG3)is a novel lncRNA and has been reported to be differentially expressed in various tumors,such as liver cancer,gastric cancer,and glioma.However,the interaction mechanisms for the regulation between SNHG3 and tumor progression are poorly understood.In this review,we summarize the results of SNHG3 studies in humans,animal models,and cells to underline the expression and role of SNHG3 in cancer.SNHG3 expression is upregulated in most tumors and is detrimental to patient prognosis.SNHG3 expression in lung adenocarcinoma remains controversial.Concurrently,SNHG3 affects oncogenes and tumor suppressor genes through various mechanisms,including competing endogenous RNA effects.A deeper understanding of the contribution of SNHG3 in clinical applications and tumor development may provide a new target for cancer diagnosis and treatment.
文摘目的探究胰腺癌患者血清长链非编码RNA-核仁小分子RNA宿主基因11(lncRNA-SNHG11)的表达水平及其临床意义。方法选择2013年7月~2015年2月邯郸市中心医院诊治的120例胰腺癌患者作为胰腺癌组,选择同期在邯郸市中心医院诊治的120例胰腺炎患者作为胰腺炎组,选择同期在该院进行体检的120例健康者作为对照组。检测胰腺癌组患者癌组织及癌旁组织lncRNA-SNHG11表达水平,比较三组血清lncRNA-SNHG11表达水平。分析血清lncRNA-SNHG11表达水平与胰腺癌患者临床病理参数之间的关系。采用Kaplan-Meier法进行生存分析。采用受试者工作特征曲线(ROC)分析血清lncRNA-SNHG11检测对胰腺癌的诊断价值。结果胰腺癌组织lncRNA-SNHG11表达水平高于癌旁正常组织(6.25±1.74 vs 1.21±0.35),差异有统计学意义(t=31.107,P=0.000)。胰腺癌组血清lncRNASNHG11表达水平(18.45±4.08)高于胰腺炎组(4.13±1.29),差异有统计学意义(t=36.659,P=0.000),胰腺炎组血清lncRNA-SNHG11表达水平高于对照组(1.05±0.31),差异具有统计学意义(t=25.431,P=0.000)。有糖尿病史、有吸烟史、肥胖、饮酒、有慢性胰腺炎、有淋巴结转移、CA199≥37U/ml,TNM分期为Ⅲ期的胰腺癌患者,血清lncRNA-SNHG11表达水平高于无糖尿病史、无吸烟史、非肥胖、不饮酒、无慢性胰腺炎、无淋巴结转移、血清CA199<37U/ml和TNM分期Ⅰ+Ⅱ期的患者(20.78±4.14 vs 17.33±3.28,20.64±4.16 vs 17.27±3.97,21.45±5.03 vs 17.11±4.22,19.75±4.17 vs 17.95±3.98,20.06±4.24 vs 18.79±3.95,21.06±3.18 vs 16.19±2.37,18.99±3.08 vs 16.29±2.27和20.97±3.23 vs 17.19±3.37),差异均有统计学意义(t=2.272~9.586,均P<0.05)。以lncRNA-SNHG11表达水平的中位数为界,将患者分为lncRNA-SNHG11低表达患者和lncRNA-SNHG11高表达患者,Kaplan-Meier生存分析结果显示,血清lncRNA-SNHG11低表达患者的5年生存率明显高于高表达患者(21.82%vs 7.69%),差异有统计学意义(Log-rankχ^(2)=6.937,P<0.05)。血清lncRNA-SNHG11检测诊断胰腺癌的曲线下面积(AUC)为0.912(95%CI:0.877~0.945),最佳截断值为18.37,灵敏度和特异度分别为0.75,0.82。CA199的AUC为0.854(95%CI:0.777~0.899),灵敏度和特异度分别为0.71,0.73。结论在胰腺癌患者中血清lncRNA-SNHG11表达水平异常升高。血清lncRNA-SNHG11高表达与淋巴结转移、TNM分期及胰腺癌患者预后密切相关,可作为胰腺癌患者诊断的辅助指标。